Literature DB >> 34866171

Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time.

Gemma E Shields1, Becky Pennington2, Ash Bullement2,3, Stuart Wright4, Jamie Elvidge5.   

Abstract

The impact of time on the applicability and relevance of historical economic evaluations can be considerable. Ignoring this may lead to the use of weak or invalid evidence to inform important research questions or resource allocation decisions, as historical economic evaluations may have reached different conclusions compared to if a similar study had been conducted more recently. There are multiple factors that contribute towards evidence becoming outdated including changes to the relevant decision problem (e.g. comparators), changes to parameters (such as costs, utilities and resource use) and methodological updates (e.g. recommendations on uncertainty analysis). Researchers reviewing economic evaluations need to consider whether changes over time would influence the study design and results if the evaluation were repeated, to the extent that it is no longer helpful or informative. In this paper, we summarise these key issues and make recommendations about how and whether researchers can future proof their economic evaluations.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Year:  2021        PMID: 34866171     DOI: 10.1007/s40273-021-01116-4

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  40 in total

Review 1.  Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Authors:  Z Philips; L Ginnelly; M Sculpher; K Claxton; S Golder; R Riemsma; N Woolacoot; J Glanville
Journal:  Health Technol Assess       Date:  2004-09       Impact factor: 4.014

Review 2.  Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria.

Authors:  Silvia Evers; Mariëlle Goossens; Henrica de Vet; Maurits van Tulder; André Ament
Journal:  Int J Technol Assess Health Care       Date:  2005       Impact factor: 2.188

3.  Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Authors:  M F Drummond; T O Jefferson
Journal:  BMJ       Date:  1996-08-03

Review 4.  Systematic reviews of health economic evaluations: A structured analysis of characteristics and methods applied.

Authors:  Miriam Luhnen; Barbara Prediger; Edmund A M Neugebauer; Tim Mathes
Journal:  Res Synth Methods       Date:  2019-03-04       Impact factor: 5.273

5.  Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report.

Authors:  Olena Lena Mandrik; J L Hans Severens; Ariel Bardach; Salah Ghabri; Candyce Hamel; Tim Mathes; Luke Vale; Torbjørn Wisløff; Jeremy D Goldhaber-Fiebert
Journal:  Value Health       Date:  2021-04       Impact factor: 5.725

6.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Authors:  Don Husereau; Michael Drummond; Stavros Petrou; Chris Carswell; David Moher; Dan Greenberg; Federico Augustovski; Andrew H Briggs; Josephine Mauskopf; Elizabeth Loder
Journal:  BMJ       Date:  2013-03-25

Review 7.  Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018.

Authors:  Rory D Watts; Ian W Li
Journal:  Value Health       Date:  2018-12-14       Impact factor: 5.725

Review 8.  Towards understanding the under-recognition of girls and women on the autism spectrum.

Authors:  Judith Gould
Journal:  Autism       Date:  2017-08

Review 9.  The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.

Authors:  Alice Tseng; Jason Seet; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

10.  Cost-effectiveness of precision medicine: a scoping review.

Authors:  Miriam Kasztura; Aude Richard; Nefti-Eboni Bempong; Dejan Loncar; Antoine Flahault
Journal:  Int J Public Health       Date:  2019-11-15       Impact factor: 3.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.